ieso joins Digital Therapeutics Alliance to Transform Global Access to Digital Mental Health Solutions
– ieso’s mission is aligned with the DTA’s mission of improving healthcare quality, outcomes, and value through optimizing the use and integration of digital therapeutics
ieso, a data-driven AI healthcare company pioneering next-generation digital therapeutics to improve mental health, announced it has joined the Digital Therapeutics Alliance (DTA), a non-profit association of industry leaders with a mission to drive awareness and adoption of digital therapies.
ieso is at the forefront of digital health transformation in mental health. Joining the Digital Therapeutics Alliance marks ieso’s entry onto the global stage, its expansion into the U.S. market, and is reflective of its longstanding commitment to research and evidence-based innovation in mental health.
“Joining the Digital Therapeutics Alliance is a huge opportunity for ieso to be at the forefront of digital therapeutic innovation and adoption in the mental health industry,” said Andy Blackwell, Chief Science and Strategy Officer, ieso. “We look forward to collaborating with leaders in the space to help define the future as we invest in and research the potential of digital therapeutics, with a focus on mental health.”
“ieso’s acceptance in joining as a new member demonstrates our commitment to the core principles of the DTA – encouraging data-driven integration and utilization of digital therapeutics across the healthcare industry, enhancing patient outcomes, and educating key stakeholders on the value and improved health outcomes delivered through digital therapeutics,” added Andy Richards, Chair, ieso.
“We are excited to welcome ieso to the DTA community to help drive advancements in the DTx industry,” said Andy Molnar, CEO of the Digital Therapeutics Alliance. “ieso’s addition further strengthens our coalition of digital therapeutics companies focused on enabling expanded access to safe and effective DTx products to improve mental health care.”
ieso’s AI-enabled digital assessment tools and therapeutics for mental health conditions will build on the insights developed from the world’s largest outcomes-linked therapy dataset, which surpasses 460,000 hours. The data encompasses insight in the treatment of common mental health conditions including depression and anxiety and those linked with long term conditions such as diabetes.
Recommended AI News: Datometry Hyper-Q Now Available in the Microsoft Azure Marketplace
[To share your insights with us, please write to email@example.com]